Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 30.16B | 30.91B | 31.91B | 31.54B | 33.38B |
Gross Profit | 2.46B | 3.17B | 3.25B | 3.21B | 3.78B |
EBITDA | 825.00M | 1.54B | 1.48B | 1.47B | 2.46B |
Net Income | 167.00M | 587.00M | 630.00M | 627.00M | 1.19B |
Balance Sheet | |||||
Total Assets | 24.55B | 27.69B | 28.16B | 27.55B | 27.11B |
Cash, Cash Equivalents and Short-Term Investments | 7.03B | 11.18B | 10.71B | 10.68B | 9.27B |
Total Debt | 34.00M | 33.00M | 25.00M | 25.00M | 38.00M |
Total Liabilities | 10.99B | 14.04B | 14.81B | 15.01B | 15.45B |
Stockholders Equity | 13.56B | 13.65B | 13.36B | 12.54B | 11.52B |
Cash Flow | |||||
Free Cash Flow | -3.55B | 831.00M | 1.35B | 1.70B | 561.00M |
Operating Cash Flow | -3.15B | 1.82B | 2.14B | 2.43B | 1.10B |
Investing Cash Flow | -600.00M | -1.00B | -793.00M | -752.00M | -520.00M |
Financing Cash Flow | -402.00M | -351.00M | -297.00M | -267.00M | -250.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥107.87B | 17.44 | 2.39% | 2.35% | 25.15% | ||
77 Outperform | ¥79.20B | 17.73 | 5.69% | 7.21% | 11.22% | ||
74 Outperform | ¥151.03B | 18.16 | 5.48% | -7.59% | 18.77% | ||
73 Outperform | ¥52.08B | 13.60 | 6.22% | 12.86% | 41.64% | ||
71 Outperform | ¥268.02B | 13.92 | 8.47% | 2.88% | 6.35% | 13.11% | |
71 Outperform | ¥44.23B | 8.66 | 3.85% | -1.39% | 16.32% | ||
60 Neutral | ¥14.13B | 85.17 | 2.58% | -2.45% | -71.57% |